Globus Medical GMED Inventory write-downs
Inventory write-downs at other companies
Other financials
Where this comes from
Reported directly by Globus Medical in its filing.
Tagged under the XBRL concept us-gaap:InventoryWriteDown.
The official record: Globus Medical’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Globus Medical's inventory write-downs.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Globus Medical's inventory write-downs?
- Globus Medical (GMED) reported inventory write-downs of $4.96M in Q1 2026.
- How has Globus Medical's inventory write-downs changed year-over-year?
- Globus Medical's inventory write-downs decreased by 16.8% year-over-year, from $5.96M to $4.96M.
- What is the long-term trend for Globus Medical's inventory write-downs?
- Over 4 years (2021 to 2025), Globus Medical's inventory write-downs has grown at a 37.8% compound annual growth rate (CAGR), from $6.14M to $22.12M.
- What does inventory write-downs mean?
- A non-cash charge for inventory that is no longer worth its original cost.
- How do you interpret inventory write-downs?
- An increase suggests potential issues with inventory management, product obsolescence, or declining demand.
- How does inventory write-downs compare across companies?
- Peers in the medical device industry typically keep this low; spikes indicate supply chain or product lifecycle issues.